PhaseFolio
**Biotech rNPV / probability-of-success engine for AI agents.** Audit-grade asset valuation with signed dossier exports, cell-level evidence registers, and asset-anchored competitive landscape — the same engine healthcare investors and tech transfer offices use to value early-stage biotech assets, exposed directly to your AI analyst. ### Tools **Public tier — no auth required** - `query_benchmarks` — anonymized network statistics (PoS by indication × modality, cost / durat